Track NRC in your personal workspace
Monitor performance, SPY relative strength
and WOI View from your watchlist.
Alert me when NRC price is:
52W Range Position
71%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-03 01:00 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 20.29. Holding above 18.14 keeps the current thesis intact.
⚖️
✓
Fundamentals
Improving / Strong
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
18.14
↗
Break Above
Confirmation improves above resistance.
20.29
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 18.14
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
28
●
Financial Results
HIGH
NRC reports financial results
On July 28, 2026, NRC Health, a Delaware corporation (the "Company"), issued a press release announcing its financial and operating results for the second quarter ended June 30, 2026.
8-K Filing•SEC EDGAR
APR
28
●
Management / Board
MEDIUM
NRC board and management update
On April 27, 2026, the Compensation and Talent Committee (the “Committee”) of the Board of Directors (the “Board”) of NRC Health (the “Company”) approved amendments to the following previously granted equity awards (collectively, the “Amended Awards”): ● 500,000 shares of stock granted on June 1, 2025, to Trent Gree...
On April 27, 2026, the Compensation and Talent Committee (the “Committee”) of the Board of Directors (the “Board”) of NRC Health (the “Company”) approved amendments to the following previously granted equity awards (collectively, the “Amended Awards”): ● 500,000 shares of stock granted on June 1, 2025, to Trent Green, the Company’s Chief Executive Officer and a member of the Board; ● 100,000 shares of stock granted on April 7, 2025, to Helen Hrdy, the Company’s Chief Operating Officer and EVP; and ● 100,000 shares of stock granted on April 7, 2025, to Andrew Monich, the Company’s Chief Corporate Development Officer and EVP.
8-K Filing•SEC EDGAR
APR
28
●
Financial Results
HIGH
NRC HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the first quarter 2026.
8-K Filing•SEC EDGAR
What's Driving NRC?
📈 Technical recovery is improving
Momentum is Neutral. Watch 20.29 for confirmation and 18.14 for structure risk.
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
42.7
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 18.14 and resistance at 20.29. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.